Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Clinical Chemistry|June 6, 2023
A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary AldosteronismMehrdad Yazdanpanah, Sarah R Delaney, Daniel R BeriaultCells|October 27, 2022
Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of ChemoresistanceToshimichi Onuma, Meshach Asare-Werehene, Yoshio Yoshida, et al.Cells|July 27, 2026
Natural Killer Cell Plasticity in Epithelial Ovarian Cancer and Their Therapeutic ImplicationsToshimichi Onuma, Meshach Asare-Werehene, Makoto Orisaka, et al.Clinical Biochemistry|March 15, 2025
The case of a bloody mess - Bictegravir/emtricitabine/tenofovir alafenamide induced colitisMeshach Asare-Werehene, Mary Kathryn Bohn, Allison Ming-Freckleton, et al.Clinical Biochemistry|November 22, 2024
Discordance between creatinine and cystatin C-based estimation of glomerular filtration rate (eGFR) in solid organ transplant recipientsMary Kathryn Bohn, Meshach Asare-Werehene, Felix Leung, et al.Cells|June 19, 2024
Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian CancerToshimichi Onuma, Meshach Asare-Werehene, Yuko Fujita, et al.Plos One|January 13, 2026
RamanBot: Versatile high throughput Raman systemKhaled Atia, Robert Hunter, Meshach Asare-Werehene, et al.Clinical Biochemistry|October 17, 2021
Validating the NIH LDL-C equation in a specialized lipid cohort: Does it add up?Victoria Higgins, Lawrence A Leiter, Sarah R Delaney, et al.BMC Cancer|May 26, 2020
Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancerHideaki Tsuyoshi, Makoto Orisaka, Yuko Fujita, et al.Journal of Ovarian Research|January 12, 2024
The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistanceHafiza Bushra Manzoor, Meshach Asare-Werehene, Satyajit Dey Pereira, et al.Pageof 8